Initiation of SGLT2i vs GLP1-RA and incidence of AKI in persons with type 2 diabetes mellitus

被引：0
|
作者：
Jensen, Simon Kok
Heide-Jorgensen, Uffe
Andersen, Ina Trolle
Thomsen, Reimar
Christiansen, Christian Fynbo
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Aarhus, Denmark
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.111
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
462
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
    Morton, Jedidiah, I
    Marquina, Clara
    Shaw, Jonathan E.
    Liew, Danny
    Polkinghorne, Kevan R.
    Ademi, Zanfina
    Magliano, Dianna J.
    DIABETOLOGIA, 2023, 66 (04) : 642 - 656
  • [42] Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
    Jedidiah I. Morton
    Clara Marquina
    Jonathan E. Shaw
    Danny Liew
    Kevan R. Polkinghorne
    Zanfina Ademi
    Dianna J. Magliano
    Diabetologia, 2023, 66 : 642 - 656
  • [43] Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes
    Mishriky, Basem M.
    Cummings, Doyle M.
    Powell, James R.
    PRIMARY CARE DIABETES, 2022, 16 (03) : 471 - 473
  • [44] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Anson, Matthew
    Zhao, Sizheng S.
    Austin, Philip
    Ibarburu, Gema H.
    Malik, Rayaz A.
    Alam, Uazman
    DIABETOLOGIA, 2023, 66 (10) : 1869 - 1881
  • [45] SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
    Matthew Anson
    Sizheng S. Zhao
    Philip Austin
    Gema H. Ibarburu
    Rayaz A. Malik
    Uazman Alam
    Diabetologia, 2023, 66 : 1869 - 1881
  • [46] EFFICACY OF SGLT2I IN ACUTE DECOMPENSATED HEART FAILURE WITH TYPE 2 DIABETES MELLITUS
    Long Doan
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E304 - E304
  • [47] Outcomes of Heart Failure with Preserved Ejection Fraction with GLP1RA plus SGLT2i vs SGLT2i alone: A Propensity-Matched Nationwide Cohort Study
    Almas, Talal
    Al-Kindi, Sadeer
    Akbar, Absam
    Qureshi, Amal
    Perez, Jaime Abraham
    Harper, Elleson Grace
    Syed, Saif
    Alazazzi, Hosam
    Sullivan, Claire
    Neeland, Ian
    Deshmukh, Abhishek
    Anavekar, Nandan
    CIRCULATION, 2024, 150
  • [48] Do GLP-1RA and SGLT2i Reduce Cardiovascular Mortality in African American Patients with Type 2 Diabetes? A Meta-analysis
    Mishriky, Basem M.
    Powell, James R.
    Wittwer, Jennifer A.
    Chu, Jennifer X.
    Sewell, Kerry
    Wu, Qiang
    Cummings, Doyle M.
    DIABETES, 2019, 68
  • [49] Risk of Urogenital Infections in Patients with Type 2 Diabetes Initiating SGLT2i Versus GLP-1RA: A Danish Emulated Target Trial
    Ljungberg, Christine
    Kristensen, Frederik P. B.
    Dalager-Pedersen, Michael
    Vandenbroucke-Grauls, Christina
    Norgaard, Mette
    Thomsen, Reimar W. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 46 - 46
  • [50] Risk-Benefit of SGLT2 Inhibitors (SGLT2i) vs. GLP-1 Receptor Agonists (GLP-1RA) in Routine Care of Older Adults
    Patorno, Elisabetta
    Kim, Dae H.
    Pawar, Ajinkya
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Munshi, Medha
    Bessette, Lily G.
    Kim, Seoyoung C.
    DIABETES, 2019, 68
12345